Pomalidomide: A new IMiD with remarkable activity in both multiple myeloma and myelofibrosis

Research output: Contribution to journalArticle

16 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)95-96
Number of pages2
JournalAmerican Journal of Hematology
Volume85
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Pathologic Neovascularization
Primary Myelofibrosis
Thalidomide
Immunologic Factors
Multiple Myeloma
Signal Transduction
Cytokines
pomalidomide

ASJC Scopus subject areas

  • Hematology

Cite this

@article{627ce062784542219ff829b70a8e39ff,
title = "Pomalidomide: A new IMiD with remarkable activity in both multiple myeloma and myelofibrosis",
author = "Martha Lacy and Rajkumar, {S Vincent}",
year = "2010",
month = "2",
doi = "10.1002/ajh.21610",
language = "English (US)",
volume = "85",
pages = "95--96",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Pomalidomide

T2 - A new IMiD with remarkable activity in both multiple myeloma and myelofibrosis

AU - Lacy, Martha

AU - Rajkumar, S Vincent

PY - 2010/2

Y1 - 2010/2

UR - http://www.scopus.com/inward/record.url?scp=75449101150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75449101150&partnerID=8YFLogxK

U2 - 10.1002/ajh.21610

DO - 10.1002/ajh.21610

M3 - Article

C2 - 20095057

AN - SCOPUS:75449101150

VL - 85

SP - 95

EP - 96

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 2

ER -